Independent directory Public ClinicalTrials.gov records United States
Clinical Trials Finder
Objective public record navigation
Search Results

Search by objective public record fields.

Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results are retrieved from ClinicalTrials.gov and synchronized into the directory. Search pages remain noindex by default.

Clear filters
ClinicalTrials.gov public records Last synced Sep 6, 2026, 9:49 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1–24 of 212 matching trials from the live ClinicalTrials.gov search.
Local D1 index available.
Filters: Intervention: HPV Vaccinations Clear all
Completed Not applicable Interventional Accepts healthy volunteers

Marketability of a Technology-based Intervention to Increase HPV Vaccination

NCT03497936
View directory record Official record
Conditions
Human Papilloma Virus
Interventions
Women's Stories
Behavioral
Lead sponsor
Real Prevention, LLC
Industry
Eligibility
18 Years to 26 Years · Female only
Enrollment
360 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2018 – 2021
U.S. locations
7
States / cities
Irvine, California • Chicago, Illinois • St Louis, Missouri + 3 more
Source: ClinicalTrials.gov public record
Updated Sep 18, 2022 · Synced Sep 6, 2026, 9:49 PM EDT
Recruiting Not applicable Interventional

Provider Recommendation and HPV Vaccination

NCT05365048
View directory record Official record
Conditions
Human Papillomavirus
Interventions
Local Tailoring implementation strategy, Prescribed Strategy
Other
Lead sponsor
Kaiser Permanente
Other
Eligibility
21 Years to 70 Years
Enrollment
301,201 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2022 – 2026
U.S. locations
1
States / cities
Pasadena, California
Source: ClinicalTrials.gov public record
Updated May 19, 2025 · Synced Sep 6, 2026, 9:49 PM EDT
Completed Not applicable Interventional Accepts healthy volunteers

Video-Assisted Counseling for HPV Vaccination

NCT03510091
View directory record Official record
Conditions
Human Papillomavirus Infection
Interventions
Counseling
Behavioral
Lead sponsor
Le Bonheur Children's Hospital
Other
Eligibility
9 Years to 99 Years
Enrollment
21 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2018 – 2019
U.S. locations
1
States / cities
Memphis, Tennessee
Source: ClinicalTrials.gov public record
Updated Dec 11, 2023 · Synced Sep 6, 2026, 9:49 PM EDT
Completed No phase listed Observational

Human Papillomavirus (HPV) Vaccination Among Survivors of Childhood Cancer

NCT01117389
View directory record Official record
Conditions
Human Papillomavirus
Interventions
Not listed
Lead sponsor
St. Jude Children's Research Hospital
Other
Eligibility
9 Years to 26 Years · Female only
Enrollment
587 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2010 – 2012
U.S. locations
1
States / cities
Memphis, Tennessee
Source: ClinicalTrials.gov public record
Updated Aug 26, 2015 · Synced Sep 6, 2026, 9:49 PM EDT
Completed Not applicable Interventional Accepts healthy volunteers Results available

txt2protect: Using Text Messaging to Increase HPV Vaccination Among Young Sexual Minority Men

NCT02994108
View directory record Official record
Conditions
Human Papillomavirus
Interventions
txt2protect, Sexual Health Control
Behavioral
Lead sponsor
Northwestern University
Other
Eligibility
18 Years to 25 Years · Male only
Enrollment
150 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2018 – 2019
U.S. locations
1
States / cities
Chicago, Illinois
Source: ClinicalTrials.gov public record
Updated Jul 19, 2020 · Synced Sep 6, 2026, 9:49 PM EDT
Suspended Not applicable Interventional Accepts healthy volunteers

HPV Vaccine Confident Families

NCT06002282
View directory record Official record
Conditions
Human Papillomavirus Vaccines
Interventions
Tailored messages, Standard messages
Behavioral
Lead sponsor
Rutgers, The State University of New Jersey
Other
Eligibility
18 Years to 80 Years
Enrollment
70 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2025 – 2026
U.S. locations
1
States / cities
New Brunswick, New Jersey
Source: ClinicalTrials.gov public record
Updated Aug 10, 2025 · Synced Sep 6, 2026, 9:49 PM EDT
Completed No phase listed Observational

Parent-son-provider Decision-making About HPV Vaccination

NCT01284374
View directory record Official record
Conditions
Human Papillomavirus Vaccination
Interventions
Not listed
Lead sponsor
Indiana University
Other
Eligibility
13 Years to 17 Years
Enrollment
62 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2011 – 2012
U.S. locations
1
States / cities
Indianapolis, Indiana
Source: ClinicalTrials.gov public record
Updated Dec 16, 2012 · Synced Sep 6, 2026, 9:49 PM EDT
Completed Not applicable Interventional Accepts healthy volunteers

Multi-component Interventions to Increase HPV Vaccination in a Network of Pediatric Clinics

NCT03111251
View directory record Official record
Conditions
Human Papillomavirus (HPV)
Interventions
Provider assessment and feedback, Provider reminders, Provider education, Patient reminders, Parent education
Behavioral
Lead sponsor
The University of Texas Health Science Center, Houston
Other
Eligibility
11 Years to 17 Years
Enrollment
1,000 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2015 – 2019
U.S. locations
1
States / cities
Houston, Texas
Source: ClinicalTrials.gov public record
Updated May 20, 2020 · Synced Sep 6, 2026, 9:49 PM EDT
Completed Not applicable Interventional Accepts healthy volunteers

Human Papillomavirus Education Programs

NCT04880837
View directory record Official record
Conditions
Human Papillomavirus-Related Carcinoma
Interventions
Educational Intervention, Informational Intervention, Survey Administration
Other
Lead sponsor
Ohio State University Comprehensive Cancer Center
Other
Eligibility
18 Years and older
Enrollment
12 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2022
U.S. locations
1
States / cities
Columbus, Ohio
Source: ClinicalTrials.gov public record
Updated Nov 1, 2023 · Synced Sep 6, 2026, 9:49 PM EDT
Completed Not applicable Interventional

HPV Centralized R/R RCT #2 - New York State

NCT03294551
View directory record Official record
Conditions
Vaccines
Interventions
HPV Vaccine Reminder Recall - Autodialer, HPV Vaccine Reminder Recall - Texting
Behavioral
Lead sponsor
University of California, Los Angeles
Other
Eligibility
11 Years to 14 Years
Enrollment
37,003 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2017 – 2019
U.S. locations
1
States / cities
Los Angeles, California
Source: ClinicalTrials.gov public record
Updated May 26, 2021 · Synced Sep 6, 2026, 9:49 PM EDT
Completed Not applicable Interventional Accepts healthy volunteers Results available

Communication Strategy to PROMOTE HPV Vaccination in Pharmacies: PROMOTE Study

NCT04660331
View directory record Official record
Conditions
Human Papillomavirus Infection
Interventions
Communication Intervention, Communication Skills Training, Healthcare Activity, Survey Administration
Other · Behavioral
Lead sponsor
Fred Hutchinson Cancer Center
Other
Eligibility
18 Years and older
Enrollment
42 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2021 – 2023
U.S. locations
1
States / cities
Seattle, Washington
Source: ClinicalTrials.gov public record
Updated Oct 8, 2024 · Synced Sep 6, 2026, 9:49 PM EDT
Completed Not applicable Interventional Accepts healthy volunteers Results available

An Intervention Study To Improve Human PapillomaVirus ( HPV) Immunization in Haitian and African American Girls

NCT01254669
View directory record Official record
Conditions
Cervical Cancer
Interventions
BNI-brief Negotiated Interview
Behavioral
Lead sponsor
Boston Medical Center
Other
Eligibility
11 Years to 15 Years · Female only
Enrollment
200 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2011 – 2014
U.S. locations
1
States / cities
Boston, Massachusetts
Source: ClinicalTrials.gov public record
Updated May 18, 2017 · Synced Sep 6, 2026, 9:49 PM EDT
Completed Not applicable Interventional Accepts healthy volunteers

Hashtag HPV: HPV Vaccine Twitter Education Program

NCT05204030
View directory record Official record
Conditions
Human Papilloma Virus, Vaccine-Preventable Diseases
Interventions
HPV Twitter Education Program - Narrative, HPV Twitter Education Program - Non-Narrative
Other
Lead sponsor
University of Arkansas, Fayetteville
Other
Eligibility
18 Years and older
Enrollment
28 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2021 – 2024
U.S. locations
1
States / cities
Fayetteville, Arkansas
Source: ClinicalTrials.gov public record
Updated Jul 26, 2026 · Synced Sep 6, 2026, 9:49 PM EDT
Recruiting No phase listed Observational Accepts healthy volunteers

Prospective Assessment of HPV Associated Anogenital Pathology in Female Patients and Female Partners of Patients With Confirmed HPV Associated Oropharyngeal Carcinoma, PAP-OP Study

NCT06115772
View directory record Official record
Conditions
Oropharyngeal Human Papillomavirus-Positive Squamous Cell Carcinoma
Interventions
Non-Interventional Study
Other
Lead sponsor
Mayo Clinic
Other
Eligibility
18 Years and older · Female only
Enrollment
154 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2022 – 2027
U.S. locations
1
States / cities
Rochester, Minnesota
Source: ClinicalTrials.gov public record
Updated Aug 4, 2026 · Synced Sep 6, 2026, 9:49 PM EDT
Completed Not applicable Interventional Accepts healthy volunteers

The STOP-HPV Trial 2: Performance Feedback Intervention

NCT03599570
View directory record Official record
Conditions
Immunization, Vaccination
Interventions
STOP-HPV performance feedback intervention
Behavioral
Lead sponsor
University of California, Los Angeles
Other
Eligibility
11 Years to 17 Years
Enrollment
48 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2018 – 2020
U.S. locations
1
States / cities
Itasca, Illinois
Source: ClinicalTrials.gov public record
Updated Apr 29, 2020 · Synced Sep 6, 2026, 9:49 PM EDT
Withdrawn Phase 1 Interventional Accepts healthy volunteers

TA-CIN Vaccine With Anti-PD-1 Therapy in Recurrent HPV16-associated Cancers

NCT05132803
View directory record Official record
Conditions
Recurrent Human Papillomavirus Type 16 Associated Cancer
Interventions
HPV 16 TA-CIN
Drug
Lead sponsor
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Other
Eligibility
19 Years and older · Female only
Healthy volunteers
Accepts healthy volunteers
Timeline
2021 – 2022
U.S. locations
2
States / cities
Birmingham, Alabama • Baltimore, Maryland
Source: ClinicalTrials.gov public record
Updated Nov 30, 2022 · Synced Sep 6, 2026, 9:49 PM EDT
Completed Not applicable Interventional Results available

Multilevel Interventions to Enhance Provider Recommendations for HPV Vaccination

NCT03501992
View directory record Official record
Conditions
Papillomavirus Vaccines
Interventions
Current care, Reminder-recall, Audit-and-feedback, Combined reminder-recall and audit-and-feedback
Behavioral
Lead sponsor
Mayo Clinic
Other
Eligibility
11 Years to 12 Years
Enrollment
9,242 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2018 – 2023
U.S. locations
1
States / cities
Rochester, Minnesota
Source: ClinicalTrials.gov public record
Updated Oct 23, 2024 · Synced Sep 6, 2026, 9:49 PM EDT
Active, not recruiting Phase 1Phase 2 Interventional Results available

A Vaccine (PDS0101) Alone or in Combination With Pembrolizumab for the Treatment of Locally Advanced Human Papillomavirus-Associated Oropharynx Cancer

NCT05232851
View directory record Official record
Conditions
Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Human Papillomavirus-Related Carcinoma, Locally Advanced Oropharyngeal Carcinoma, Stage IVA Oropharyngeal (p16-Negative) Carcinoma AJCC v8, Stage IVB Oropharyngeal (p16-Negative) Carcinoma AJCC v8
Interventions
Liposomal HPV-16 E6/E7 Multipeptide Vaccine PDS0101, Pembrolizumab, Computed Tomography, FDG-Positron Emission Tomography, Biospecimen Collection, Biopsy
Biological · Procedure
Lead sponsor
Mayo Clinic
Other
Eligibility
18 Years and older
Enrollment
20 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2022 – 2026
U.S. locations
1
States / cities
Rochester, Minnesota
Source: ClinicalTrials.gov public record
Updated Apr 13, 2026 · Synced Sep 6, 2026, 9:49 PM EDT
Completed Not applicable Interventional Accepts healthy volunteers Results available

An Evaluation of Tailored Messages to Address Parental Questions About HPV Vaccination

NCT03628885
View directory record Official record
Conditions
Human Papilloma Virus Vaccines, Attitude to Health
Interventions
Top Concern Tailored Intervention, All Concerns Tailored Intervention
Behavioral
Lead sponsor
Indiana University
Other
Eligibility
18 Years and older · Female only
Enrollment
908 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2018
U.S. locations
1
States / cities
Indianapolis, Indiana
Source: ClinicalTrials.gov public record
Updated Apr 1, 2019 · Synced Sep 6, 2026, 9:49 PM EDT
Completed Not applicable Interventional

HPV Vaccination: Evaluation of Reminder Prompts for Doses 2 & 3

NCT02558803
View directory record Official record
Conditions
Human Papilloma Virus Infection Type 11, Human Papilloma Virus Infection Type 16, Human Papilloma Virus Infection Type 18, Human Papilloma Virus Infection Type 6, Cervical Cancer, Genital Warts, Oropharyngeal Cancer
Interventions
Simple Reminder
Behavioral
Lead sponsor
Regenstrief Institute, Inc.
Other
Eligibility
11 Years to 17 Years
Enrollment
1,305 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2015 – 2016
U.S. locations
5
States / cities
Indianapolis, Indiana
Source: ClinicalTrials.gov public record
Updated May 24, 2016 · Synced Sep 6, 2026, 9:49 PM EDT
Completed No phase listed Observational Accepts healthy volunteers

Immune Memory After Papillomavirus Vaccination

NCT01505049
View directory record Official record
Conditions
Healthy Volunteers
Interventions
quadrivalent HPV vaccine
Drug
Lead sponsor
Emory University
Other
Eligibility
18 Years to 30 Years · Female only
Enrollment
203 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2012 – 2015
U.S. locations
1
States / cities
Atlanta, Georgia
Source: ClinicalTrials.gov public record
Updated Jul 20, 2015 · Synced Sep 6, 2026, 9:49 PM EDT
Completed Phase 1 Interventional

A Phase I Clinical Trial of an HPV Therapeutic Vaccine

NCT01653249
View directory record Official record
Conditions
Human Papillomavirus
Interventions
Vaccine consisting of four HPV-16 E6 peptides in combination with Candin®
Biological
Lead sponsor
University of Arkansas
Other
Eligibility
18 Years to 50 Years · Female only
Enrollment
52 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2012 – 2015
U.S. locations
1
States / cities
Little Rock, Arkansas
Source: ClinicalTrials.gov public record
Updated Oct 11, 2016 · Synced Sep 6, 2026, 9:49 PM EDT
Completed No phase listed Observational Accepts healthy volunteers

Human Papilloma Virus (HPV) Vaccination Among Rural African American Primary Caregivers and Daughters

NCT00937287
View directory record Official record
Conditions
Human Papillomavirus
Interventions
There is no intervention in this study.
Other
Lead sponsor
University of Georgia
Other
Eligibility
13 Years to 17 Years · Female only
Enrollment
410 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2009 – 2012
U.S. locations
1
States / cities
Athens, Georgia
Source: ClinicalTrials.gov public record
Updated Aug 13, 2013 · Synced Sep 6, 2026, 9:49 PM EDT
Terminated Not applicable Interventional Accepts healthy volunteers Results available

Developing a Self-persuasion Intervention Promoting Adolescent HPV Vaccination: Feasibility Trial

NCT02535845
View directory record Official record
Conditions
Human Papillomavirus Vaccines
Interventions
Project Voice, HPV Informational Video
Behavioral
Lead sponsor
University of Texas Southwestern Medical Center
Other
Eligibility
11 Years and older
Enrollment
22 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2017 – 2019
U.S. locations
1
States / cities
Dallas, Texas
Source: ClinicalTrials.gov public record
Updated Jan 29, 2024 · Synced Sep 6, 2026, 9:49 PM EDT